Commission Implementing Decision (EU) 2018/320 of 28 February 2018 on certain animal health protection measures for intra-Union trade in salamanders and the introduction into the Union of such animals in relation to the fungus Batrachochytrium salamandrivorans (notified under document C(2018) 1208) (Text with EEA relevance) (c. 320)

F1 ANNEX I U.K.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

F1 Annex 1 omitted (31.12.2020) by virtue of The Import of, and Trade in, Animals and Animal Products (Miscellaneous Amendments) (EU Exit) Regulations 2020 (S.I. 2020/1462), regs. 1(3), 67(12) (with regs. 69-71)

ANNEX II U.K. MINIMUM CONDITIONS FOR APPROPRIATE ESTABLISHMENTS OF DESTINATION

(1) The appropriate establishment of destination: U.K.

(a)

has a system that ensures adequate surveillance of the salamanders;

(b)

is under the control of an official or approved veterinarian;

(c)

is cleaned and disinfected in accordance with instructions by the competent authority.

(2) The operator of the appropriate establishment ensures that: U.K.

(a)

cleaning and disinfection of the tanks, crates or other fomites used for the transport of the salamanders is carried out unless those are destroyed, in a way to prevent the spread of Bsal.

(b)

waste material and waste water is collected regularly, stored and subsequently treated in a way to prevent the spread of Bsal.

(c)

carcases of quarantined salamanders are examined in a laboratory indicated by the competent authority.

(d)

the necessary tests and treatments of salamanders are carried out in consultation with and under the control of the official or approved veterinarian.

(3) The operator of the appropriate establishments of destination informs the official or approved veterinarian of diseases and deaths of salamanders during the quarantine. U.K.

(4) The operator of the appropriate establishments of destination keeps a record of: U.K.

(a)

the date, number and species of salamanders entering and leaving for each consignment;

(b)

copies of the animal health certificates and the common [F2 health] entry documents accompanying the consignment of salamanders;

(c)

cases of illness and the number of deaths on a daily basis;

(d)

dates and results of testing;

(e)

types and dates of treatment and the number of animals subjected to it.

Textual Amendments

F2 Word in Annex 2 point (4)(b) substituted (31.12.2020) by The Import of, and Trade in, Animals and Animal Products (Miscellaneous Amendments) (EU Exit) Regulations 2020 (S.I. 2020/1462), regs. 1(3), 67(13) (with regs. 69-71)

ANNEX III U.K. EXAMINATION, SAMPLING, TESTING AND TREATMENT PROCEDURES FOR BSAL

(1) During quarantine, the salamanders are subjected to the following procedures: U.K.

(a)

If the size of the epidemiological unit is 62 or more, skin swab samples from quarantined salamanders must be examined under the control of the official or approved veterinarian with the appropriate diagnostic test during the fifth week following the date of their entry into the appropriate establishment, in accordance with the sample sizes set out in the reference table, unless the operator opts for treatment in accordance with point (b).

Reference Table^a:

a Assuming 3 % prevalence of Bsal in the epidemiological unit and ensuring its detection with a 95 % confidence rate with the sensitivity of the appropriate diagnostic test calculated to be at 80 %.
Size of the epidemiological unit	62	186	200	250	300	350	400	450
Sample size	62	96	98	102	106	108	110	111

(b)

If the operator opts for one of the treatments listed in point (3) or in all cases where the size of the epidemiological unit is less than 62, all salamanders in the consignment must be treated by the operator against Bsal under the control of the official or approved veterinarian to the satisfaction of the competent authority.

(c)

In cases referred to in point (b) the official or approved veterinarian may require representative testing of the epidemiological unit with the appropriate diagnostic test before the treatment to monitor the presence of Bsal or after treatment to verify the absence of Bsal.

(d)

Skin swab samples from all dead or clinically sick salamanders, in particular those with skin lesions, must be examined under the control of the official or approved veterinarian with the appropriate diagnostic test at the time they show lesions or other clinical signs or at the time of death, whichever is sooner.

(e)

All salamanders which die in the appropriate establishment must be subjected to a post mortem examination under the control of the official or approved veterinarian, in particular to check for signs of Bsal, to confirm or to exclude Bsal as cause of death, to the extent possible.

(2) All testing of samples taken and post mortem examination during quarantine must be carried out in laboratories indicated by the official or approved veterinarian. U.K.

(3) The following treatments are considered to be satisfactory: U.K.

(a)

keeping salamanders at a temperature of at least 25 °C for at least 12 days;

(b)

keeping salamanders at a temperature of at least 20 °C for at least 10 days combined with a treatment with polymyxin E submersion baths (2 000 IU/ml) for 10 minutes twice per day, followed by applying voriconazole spray (12,5 μg/ml);

(c)

any other treatment with comparable results in eliminating Bsal as reported in a peer-reviewed article published in a scientific journal.